fda warning glp-1 october 2025 Compound versions of drugs for weight loss halted by New project announcement: HHS‑OIG is

The FDA committee was tasked with reviewing data that supports using these peptides to treat a variety of specific conditions, such as BPC-157 for treating ulcerative colitis, an inflammatory bowel disease

If testing reveals anatomical changes such as: Significant sleeve dilation Reflux due to sleeve anatomy A dilated gastric pouch A dilated gastrojejunal anastomosis Band complications As a surgeon specializing in revisions and conversions, you are uniquely positioned to guide patients through this decision

doi: 10.3389/fnmol.2023.1219574 40

[6] Supplementation with L-carnitine showed improvements on the Clinical Global Impression Scale (CGIS) and other clinical variables